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Regucalcin (RGN), also reported as senescence marker protein-30 (SMP30), plays a role in Ca2+
homeostasis by modulating a number of Ca2+-dependent proteins. RGN also plays a cyto-protective
role and its decrease is linked to age-related diseases and cell death. This study shows that RGN
reduces agonist (histamine)-induced Ca2+ transients in RGN+ transfected COS-7 cells (RGN+) and also
increases their Ca2+ storage capacity. These observations are explained by RGN+ cells having
increased mRNA and protein expression levels of sarco/endoplasmic reticulum Ca2+-ATPase (SERCA).
Therefore down-regulation of RGN expression may contribute to characteristics of age-dependent
Ca2+ homeostasis dis-regulation, by decreasing SERCA levels.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Regucalcin was ﬁrst identiﬁed in the late 1970s as an abundant
Ca2+-binding protein in rat liver [1], which was involved in regulat-
ing Ca2+ signalling [2]. It has since been shown to be expressed in a
wide variety of other tissues [2,3]. Although predominantly found
in the cytosol, it has also been found in the nucleus [4] and mito-
chondria [5]. The expression levels of RGN protein in some tissues
is age-dependent, and therefore commonly referred to as senes-
cence marker protein-30 (SMP30) [6]. RGN increases steadily dur-
ing neonatal development rising to a maximum in early adulthood.
The level of RGN then drops substantially in old age [6]. Changes in
the expression of RGN has been associated with a number of path-
ological conditions, such as cancer [3], Alzheimer’s disease [7] and
osteoporosis [3,8]. Furthermore, RGN knockout mice have been
shown to have a number of conditions often associated with old
age including; hearing loss [9], increased lipid accumulation in
the liver [8] and poor glucose tolerance [8,10].
RGN is a multifunctional protein playing several different func-
tions inside cells. It was ﬁrst shown to play a regulatory role in Ca2+
homeostasis by modulating the activity Ca2+-binding proteins,
such as Ca2+-ATPases/Ca2+ pumps [2,11–13], calpain [2] andchemical Societies. Published by E
e marker protein 30; SERCA,
R, polymerase chain reaction
chelangeli).Ca2+-dependent protein kinases such as camodulin-kinase and
PKC [2,3]. Secondly, RGN has been shown to have intrinsic enzy-
matic activity, acting as a gluconolactonase which is involved in
the biosynthesis of vitamin C in some mammals [14]. It may also
act as a detoxifying enzyme in the liver as it can metabolise toxins
such as diisopropyl-phosphoﬂuoridate [15]. Thirdly, RGN over-
expression in NRK52E cells can repress the expression of L-type
Ca2+ channel and the Ca2+-sensing receptor [16], suggesting that
RGN may also be a transcriptional regulator. All of these roles
may therefore work in concert to account for its cyto-protective
effects to oxidative stress and toxic insult [2,3,17].
Given RGNs ability to stimulate Ca2+-ATPases [2,11–13], the
main aim of this study was to examine whether RGN expression
can modulate intracellular [Ca2+] transients caused by agonist
stimulation or thapsigargin within cells.
2. Materials and methods
Anti-RGN was a custom-made polyclonal antibody from
Covalab, using the full length rat recombinant RGN protein as the
antigen. Anti-SERCA antibody (Y1F4) was a gift from Dr. Malcolm
East, University of Southampton, UK. Both SMP30-pcDNA3.1()
(containing human RGN coding insert) and control pcDNA3.1()
(with no coding sequence insert) plasmids were gifts from Prof. J.
Lee (Pusan National University, Korea). Cells transfected with
either the SMP30 containing plasmid or the empty plasmid are
referred to as RGN+ or RGN, respectively.lsevier B.V. All rights reserved.
Fig. 1. Over-expression and localisation of Regucalcin in COS-7 cells. (A) Immuno-
blot of lysates (20 lg) of RGN+ or RGN cells, where the proteins were immuno-
stained with the anti-RGN antibody. (B) PCR product of cDNA prepared from RGN+
and RGN mRNA and probed with RGN primers. (C) Transfected cells immuno-
stained with the anti-RGN antibody. The blots, gels and immuno-micrographs are
typical of three replicated experiments.
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glucose) (Lonza), supplemented with 10% v/v FBS (Lonza), 2 mM
L-glutamine and 1% v/v penicillin-streptomycin (PAA). For trans-
fection, they were seeded at a density of 1  105 cells per well of
a 12-well plate (or onto coverslips) and Genejuice transfection
reagent (Novagen) with plasmid DNA was used following manu-
facturer’s instructions. Transfection was done 24 h after seeding
cells and transfected cells were used 48 h after transfection.
mRNA from RGN+ and RGN cells were extracted and converted
into cDNA as described in [18]. The level of cDNA (corresponding to
mRNA for speciﬁc gene products) was quantiﬁed via PCR ampliﬁca-
tion using appropriate primers. In all PCR reactions; BIOTAQTM
(2.5U/ reactions), 2 mM dNTP, 2 mM MgCl and between 10 and
30 pmol of the primers were used. The primer sequences for:
RGN were (Forward: AATGATGGGAAGGTGGATC, Reverse: GTCAT
AGTCAAAGGCATCC); for SERCA2B were (Forward: CCCTTGG
TTGTACTTCTGTTA, Reverse: CCTTCACAAACATCTTGCTC); and for
b-Actin were (Forward: ATGGATGATGATATCGCCGC; Reverse:
TGATCTGGGTCATCTTCTCG). The annealing temperatures were
47 C, 49 C and 52 C, respectively and the number of cycles was
37 for SERCA2B and b-Actin and 35 for RGN. PCR products were
then separated and visualised as described in [18].
Western blotting was as described previously [18] with the
following modiﬁcations. Lysates were prepared by adding lysis
buffer (50 mM Tris–HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton
X100, 1% sodium deoxycholate, 0.1% SDS and 1 mM PMSF, pH7.4)
to transfected cells attached to the surface of wells in a 12-well
plate. The antibody dilution ratios used were 1:50 for anti-RGN
and 1:800 for anti-SERCA (YIF4). Immunohistochemical labelling
of cells was as described previously [18] using a 1:100 dilution of
the anti-RGN.
Intracellular Ca2+ imaging was as described previously [18] but
with the following modiﬁcations: Fluo-4 AM (Invitrogen) was used
at a ﬁnal concentration of 7.5 lM. 1 lM thapsigargin or 10 lM his-
tamine (an agonist which mobilizes Ca2+ through IP3 generation)
was added to cells 1 minute after initiating recording and each
recording lasted for 5 minutes in total. In order to focus on changes
in cytosolic Ca2+ concentrations occurring from internal stores,
prior to initiating the recordings, the Hank’s buffered saline
solution was supplemented with 1.26 mM EGTA such that the cells
were in the absence of extracellular Ca2+.3. Results
Over-expression of RGN at both the protein and mRNA level
were demonstrated by the presence of an anti-RGN antibody
immuno-reactive band at 33 kDa from RGN+ cell lysates (Fig. 1A)
and the elevated level of the PCR product at 237 bp, in the cDNA
generated from RGN+ transfected COS-7 cells (Fig. 1B). Little or
no RGN was detected by either method when the cells were trans-
fected with the empty vector (RGN). Immunoﬂuorescence also
demonstrated RGN over-expression was greatly increased in cells
transfected with the RGN+ plasmid compared to RGN cells, with
predominant labelling occurring in and around the nuclear region
(Fig. 1C). Transfection efﬁciency was >70%.
Intracellular Ca2+ transients, which are represented by plots of
ﬂuorescence intensity change over time measured from transfec-
ted cells loaded with Fluo-4 AM, were visible for both RGN+ and
RGN control cells. In order to achieve statistical relevance, 5
individual transfections were undertaken and in each experiment
25 cells from the ﬁeld-of-view were analysed (individual traces),
such that each graph represented about 125 cells. Ca2+-mediated
responses were seen in both RGN+ and RGN cells when stimulated
with either 1 lM thapsigargin (Fig. 2A), or 10 lM histamine
(Fig. 2B). Analysis of the Ca2+ transients when comparing RGN+and RGN cells showed that the height of the response peaks
(from basal to maximum ﬂuorescence intensity levels) were
statistically different (P < 0.05) (n = 5 and 125 cells). Fig. 2C
shows that the mean change in peak heights in response to thapsi-
gargin for RGN+ cells were on average, 40% greater than for the
RGN cells. Whereas mean peak heights in response to 10 lM
histamine for RGN+ cells were on average 27% lower compared to
RGN cells.
One possible explanation for these ﬁndings is that RGN+ cells
could have increased levels of SERCA Ca2+ pump. Fig. 3 shows that
when the RGN+ and RGN cells where probed with an anti-SERCA
antibody, the SERCA protein levels were found to be 21% higher in
RGN+ cells than RGN cells, which was statistically signiﬁcant
(P < 0.05) (n = 3). In order to ascertain whether this increase in
SERCA was due to increased transcription rather than protein
turnover, the cDNA for SERCA2B (the isoform found in these cells)
was measured using PCR in both RGN+ and RGN cells. Again from
Fig. 3 it is clear that the transcript is greatly enhanced (an increase
of 65%) in RGN+ compared to RGN cells, while the levels of b-actin
transcript (a control) was very similar in both cells.
4. Discussion
This study has also shown that cells over-expressing RGN have
increased levels of SERCA both at the mRNA and protein level. This
study also showed that RGN+ cells had increased Ca2+ storage
capacity (as determined by the increase in thapsigargin-induced
Ca2+ mobilization) and decreased levels agonist-stimulated
cytosolic [Ca2+] transients in intact cells. These observations are
consistent with other studies in which SERCA expression was
altered within cells. In a study by Brini et al. [19] in which SERCA2B
was over-expressed in CHO cells, an increase in the ER Ca2+ pool
was also observed. In another study by Green et al. [20] using ﬁbro-
blasts in which SERCA2B was ‘knocked-down’, the level of thapsi-
gargin-induced Ca2+ release was reduced compared to control cells.
All these observations therefore indicate that SERCA levels directly
control the levels of ER luminal [Ca2+]. Furthermore, the Brini et al.
[19], study also showed that SERCA2B over-expression decreased
the amount of agonist-induced Ca2+ release into the cytoplasm.
This was explained by the fact that the opening probability of
Fig. 2. Ca2+ transients following thapsigargin and histamine stimulation of RGN+ and RGN transfected cells. Each panel (in A and B) shows ﬁve separate experiments with
each individual trace representing the mean data from 25 cells (125 cells in total). (A) Effects of 1 lM thapsigargin on RGN+ and RGN cells. (B) Effects of 10 lM histamine on
these cells. The stimulants were added about 60 s following the initiation of the recording. (C) Means of change in peak heights measured from the traces shown in A and B.
Each change in peak height was determined as the distance from basal to maximum F/F0 values reached for each trace. ⁄ Indicates that a statistically signiﬁcant difference in
peak heights between RGN+ and RGN cells were observed (⁄P < 0.05).
Fig. 3. Increased SERCA expression in RGN+ cells. The ﬁgure shows the differences in SERCA expression levels (at the protein level and mRNA levels) between RGN+ and RGN
cells. The ﬁgure shows the immuno-stained SERCA blot and the SERCA2B-speciﬁc PCR product from the cells. The PCR product for b-actin was also determined for the RGN+
and RGN cells as a control. Each experiment was repeated three times and the mean ratios ± SD, between RGN+ and RGN cells are presented. ⁄ and ⁄⁄ indicates a statistical
signiﬁcance between RGN+ and RGN cells (⁄P < 0.05 and ⁄⁄P = P < 0.01).
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such that if the ER Ca2+ stores contain higher [Ca2+] this will de-
crease the open probability of the channel causing less Ca2+ to be
released through the IP3-sensitive Ca2+ channel [21]. An alternative
explanation in our study could be that as the opening probability ofthe IP3 receptor is also regulated by kinase-dependent phosphory-
lation [22] and since RGN can also alter kinase-dependent activity
[2,3] it could be envisaged that altered phosphorylation states of
the IP3 receptor, caused by RGN over-expression, may also contrib-
ute to reduced channel opening. The role of SERCA2B in regulating
2294 P. Lai et al. / FEBS Letters 585 (2011) 2291–2294Ca2+ release through the IP3-sensitive Ca2+ channel was also
conﬁrmed in xenopus oocytes studies where over-expressing
SERCA2B caused a diminished amount of Ca2+ release induced by
low levels of photo-released IP3 compared to controls [20].
Our studies show that RGN predominantly localises in and
around the nucleus of RGN+ cells. Earlier studies have also shown
RGN to translocate from the cytosol to the nucleus and to bind to
nuclear proteins and DNA [16,23]. In addition, RGN can alter the
expression of a number of genes including those associated with
tumours. The expression of oncogene c-src mRNA was signiﬁcantly
suppressed in hepatoma cells over-expressing regucalcin, while,
the expression of the tumor suppressor gene p53, was signiﬁcantly
enhanced [23]. In these studies it was suggested that RGN is acting
as a transcriptional regulator, possibly interacting with transcrip-
tion factors or repressors. Our study now shows that RGN can also
increase the expression of SERCA2B, by directly or indirectly
enhancing transcription, possibly via similar mechanisms.
However, detailed studies to investigate the effects of RGN on
the promoter region of the SERCA2B gene would be required to
more fully elucidate this possibility.
It is well established that aging and cell death is associated with
defective Ca2+ homeostasis, particularly when cells experience
aberrant elevated levels of cytosolic Ca2+ levels [24]. SERCA plays
a fundamental role in minimising these abnormal changes [25].
Previous studies have suggested that RGN can directly bind to
and stimulate Ca2+ pump activity [2,11–13] and now from this
study we also show evidence that the expression of SERCA Ca2+
pumps has increased. Therefore during the aging process when
RGN levels fall this would concomitantly reduce SERCA levels as
well as directly reducing SERCA activity, exposing cells to abnor-
mal [Ca2+] ﬂuctuations, leading to cell death.
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